Tusseau, Maud
Khaldi-Plassart, Samira
Cognard, Jade
Viel, Sebastien
Khoryati, Liliane
Benezech, Sarah
Mathieu, Anne-Laure
Rieux-Laucat, Fréderic
Bader-Meunier, Brigitte
Belot, Alexandre
Funding for this research was provided by:
Agence Nationale de la Recherche (ANR-21-CE17-0064 SOCSIMMUNITY, ANR-21-RHUS-08 COVIFERON, ANR-21-CE17-0064 SOCSIMMUNITY)
HORIZON EUROPE Health (01057100 [UNDINE], 01057100 [UNDINE])
Article History
Received: 26 January 2024
Accepted: 25 March 2024
First Online: 15 April 2024
Declarations
:
: All the figures were created with BioRender.com.
: AB reports consulting fees from Kabi, Roche Chugai, GlaxoSmithKline, AbbVie, Novartis, and Boehringer Ingelheim; research grants from Boehringer Ingelheim, ANR, and Horizon Europe outside the scope of this comment; and is an unpaid co-chair of the French National Network on Rare Autoimmune and Autoinflammatory Diseases. All other authors declare no competing interests.